AstraZeneca to manufacture cancer killer in Singapore
Health
ASTRAZeneca says it will invest 1.5 billion U.S. dollars in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs).
The biopharmaceutical giant announced on Monday.
AstraZeneca aimed to start designing and construction of the manufacturing facility by the end of this year, with targeted operational readiness from 2029.
According to the company ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody. (Xinhua/NAN)
A.
-May 20, 2024 @ 11:56 GMT|
Related Posts
Tension in Oyo as doctor, 3 nurses die in same hospital within 72 hrs
RESIDENTS of Saki, in Saki West Local Government Area of Oyo State, particularly those living around Almusharaf Hospital, Oke Sunah,...
Read MoreFG to finalise guidelines on organ donation, transplantation
THE Federal Government is in the final stages of developing guidelines for organ donation and transplantation in Nigeria. Prof. Philip...
Read MoreANALYSIS: Rescuing 24.6m Nigerian children from harmful labour
By Ijeoma Popoola, CHILD labour has remained a challenge to Nigeria and many other countries. According to the International Labour...
Read MoreMost Read
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.